1. Home
  2. CRI vs ABCL Comparison

CRI vs ABCL Comparison

Compare CRI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$36.84

Market Cap

1.2B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.17

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
ABCL
Founded
1865
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
CRI
ABCL
Price
$36.84
$3.17
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$32.60
$7.75
AVG Volume (30 Days)
1.3M
5.3M
Earning Date
02-24-2026
02-24-2026
Dividend Yield
2.72%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$2,832,687,000.00
$35,325,000.00
Revenue This Year
$2.49
$25.45
Revenue Next Year
$0.10
$10.07
P/E Ratio
$15.00
N/A
Revenue Growth
N/A
7.17
52 Week Low
$23.38
$1.89
52 Week High
$54.58
$6.52

Technical Indicators

Market Signals
Indicator
CRI
ABCL
Relative Strength Index (RSI) 62.13 31.04
Support Level $32.24 $2.75
Resistance Level $38.88 $3.69
Average True Range (ATR) 1.67 0.28
MACD 0.20 -0.15
Stochastic Oscillator 85.89 8.55

Price Performance

Historical Comparison
CRI
ABCL

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: